Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Adv Cancer Res. 2010;109:1-50. doi: 10.1016/B978-0-12-380890-5.00001-6.
Prostate cancer is a major health problem as it continues to be the most frequently diagnosed cancer in men in the Western world. While improved early detection significantly decreased mortality, prostate cancer still remains the second leading cause of cancer-related death in Western men. Understanding the mechanisms of prostate cancer initiation and progression should have a significant impact on development of novel therapeutic approaches that can help to combat this disease. The recent explosion of novel high-throughput genetic technologies together with studies in animal models and human tissues allowed a comprehensive analysis and functional validation of the molecular changes. This chapter will summarize and discuss recently identified critical genetic and epigenetic changes that drive prostate cancer initiation and progression. These discoveries should help concentrate the efforts of drug development on key pathways and molecules, and finally translate the knowledge that is gained from mechanistic studies into effective treatments.
前列腺癌是一个主要的健康问题,因为它仍然是西方世界男性中最常被诊断出的癌症。虽然早期检测的改进显著降低了死亡率,但前列腺癌仍然是西方男性癌症相关死亡的第二大主要原因。了解前列腺癌发生和发展的机制应该对开发新的治疗方法产生重大影响,这些方法可以帮助对抗这种疾病。新型高通量遗传技术的最新发展,以及在动物模型和人体组织中的研究,使得对分子变化进行全面分析和功能验证成为可能。本章将总结和讨论最近发现的关键遗传和表观遗传变化,这些变化推动了前列腺癌的发生和发展。这些发现应该有助于将药物开发的努力集中在关键途径和分子上,并最终将从机制研究中获得的知识转化为有效的治疗方法。